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Abstract
The purpose of this study was to assess whether homology-based emphysema quantifica-
tion (HEQ) is significantly associated with lung cancer risk. This retrospective study was
approved by our institutional review board. We included 576 patients with lung nodules (317
men and 259 women; age, 66.8 ± 12.3 years), who were selected from a database previ-
ously generated for computer-aided diagnosis. Of these, 283 were diagnosed with lung can-
cer, whereas the remaining 293 showed benign lung nodules. HEQ was performed and
percentage of low-attenuation lung area (LAA%) was calculated on the basis of computed
tomography scans. Statistical models were constructed to estimate lung cancer risk using
logistic regression; sex, age, smoking history (Brinkman index), LAA%, and HEQ were con-
sidered independent variables. The following three models were evaluated: the base model
(sex, age, and smoking history); the LAA% model (the base model + LAA%); and the HEQ
model (the base model + HEQ). Model performance was assessed using receiver operating
characteristic analysis and the associated area under the curve (AUC). Differences in AUCs
among the models were evaluated using Delong’s test. AUCs of the base, LAA%, and HEQ
models were 0.585, 0.593, and 0.622, respectively. HEQ coefficient was statistically signifi-
cant in the HEQ model (P = 0.00487), but LAA% coefficient was not significant in the LAA%
model (P = 0.199). Delong’s test revealed significant difference in AUCs between the LAA%
and HEQ models (P = 0.0455). In conclusion, after adjusting for age, sex, and smoking his-
tory (Brinkman index), HEQ was significantly associated with lung cancer risk.
Introduction
Lung cancer is the leading cause of cancer-related deaths in the United States [1]. The National
Lung Screening Trial has demonstrated that screening high-risk individuals using low-dose
computed tomography (CT) reduced lung cancer-related mortality by 20% [2], fostering a
hope that the detection of early-stage lung cancers may enable the administration of curative
treatments. Moreover, of the 90 million current and former smokers in the United States, 9
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million have been estimated to meet the criteria for undergoing CT screening [3]. Considering
such a large number of potential screening participants, screening costs may be a major prob-
lem while determining inclusion criteria for the current screening programs.
To limit screening costs, predictive models for lung cancer risk have been investigated
in previous studies [4],[5]. In addition, it has been suggested that lung cancer risk could be
stratified using spirometry measurements and CT-based emphysema evaluations [3]. Several
studies have examined the association between lung cancer risk and CT-based emphysema
evaluation [6],[7]. A meta-analysis has confirmed significantly increased odds ratio (OR) for
lung cancer when emphysema was detected through a visual assessment [7]. However, other
studies have shown no such association between quantitative emphysema evaluations and
lung cancer risk [6],[7],[8]. Wille et al [8] have investigated the association between lung can-
cer and visual or quantitative chest CT image assessments and have confirmed that neither
percentage of low-attenuation lung area (LAA%) nor the 15th percentile density was associated
with lung cancer, although there was a significant association between lung cancer and visually
assessed emphysema and interstitial abnormalities. Overall, the utility of quantitative emphy-
sema evaluations remains controversial.
Homology methods have been used for medical image analysis in numerous studies [9–13],
some of which have demonstrated that homology-based emphysema quantification (HEQ)
was useful for assessing the severity of emphysema and for predicting results of visual scoring
of emphysema [12],[13]; these findings suggest that HEQ may be useful for estimating lung
cancer risk.
Therefore, the purpose of the present study was to evaluate whether HEQ is significantly
associated with lung cancer risk and to construct and validate an estimation model for predict-
ing lung cancer risk on the basis of HEQ and other clinical parameters. We hypothesized that
HEQ is associated with lung cancer risk.
Materials and methods
This retrospective study was approved by the institutional review board of Kyoto University
Hospital (number: R1054); the requirement of acquiring informed consent was waived. We
used a database of lung nodules, which was previously generated for computer-aided diagnosis
[14],[15]. The database includes CT images and clinical information of 1,240 patients present-
ing with at least one lung nodule. The previous studies have focused on the computer-aided
diagnosis system [14],[15], which directly uses characteristics related to lung nodules; thus, the
purpose of the current study stands different from that of the previous studies.
Database and inclusion criteria
A majority of the lung nodules in the database were diagnosed as one of three types: benign
lung nodule, primary lung cancer, or metastatic lung cancer. In the present study, we focused
on benign lung nodule and primary lung cancer. Diagnoses of all lung cancers were patholog-
ically confirmed. The diagnosis of benign lung nodules was based mainly on their stability or
shrinkage on CT scans, with the stability confirmed by a 2-year follow-up with CT; 57 of
the benign nodules were pathologically confirmed. CT scans covered the entire chest and
were acquired using a 320- or 64-detector row CT scanner (Aquilion ONE or Aquilion 64;
Toshiba Medical Systems, Otawara, Japan), with automated exposure control. Parameters of
CT scans were as follows: tube current, 109 ± 53.3 (range, 25–400) mA; gantry rotation time,
0.500 ± 0.0137 (range, 0.400–1.00) s; tube potential, 120 ± 1.69 (range, 120–135) kV; matrix
size, 512 × 512; and slice thickness, 1 or 0.5 mm.
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Patients who met the following three criteria were selected: (1) those with the lung nodule
diagnosed as benign or primary lung cancer; (2) those whose non-contrast CT scans were
available; and (3) those for whom smoking history (Brinkman Index) was clearly described.
Emphysema quantification
The lungs were automatically segmented based on chest CT images using a dedicated algo-
rithm [16], and three CT images of the upper, middle, and lower lung fields were selected for
emphysema quantification [13],[17].
LAA% was calculated as follows. The lung area was evaluated (as a number of pixels) based
on the lung segmentation of the three CT images, and the pixels within the lungs with attenua-
tion lower than a predefined threshold were counted as low-attenuation lung pixels [18]; these
values were used to calculate LAA%:
LAA% ¼
Total number of low   attenuation lung pixels on the three CT scans
Total number of lung pixels on the three CT images
:
During this process, binary versions of the CT images were created, with 1 indicating a nor-
mal lung pixel or a pixel outside the lung and 0 indicating a lung pixel with attenuation below
the defined threshold. These binary images were used for HEQ.
HEQ for the three CT images was performed as described elsewhere [12],[13]. The detailed
process of HEQ in the present study has been described in supporting information (S1 File).
The two previous studies have used the Betti numbers for HEQ [12],[13]. In a two-dimen-
sional image, the Betti numbers of homology comprise two numbers: b0 and b1. In terms of
lung CT images, b0 corresponds to the number of low-attenuation lung regions and b1 to the
number of normal lung regions surrounded by the low-attenuation lung regions. On CT
images, b0 and b1 are related to the holes formed by emphysema. Examples of binary images
and corresponding Betti numbers are shown in supporting information (S2 File). Using
dedicated software [12],[13], the Betti numbers can be calculated from the binary CT images
acquired when calculating LAA%. Thresholds for both LAA% and HEQ were −950, −910, and
−880 Hounsfield unit (HU).
Statistical analysis
Differences in age, sex, smoking history (Brinkman index), malignant tumor history, lung
area, LAA%, and HEQ (b0 and b1) were compared between the patients with and without lung
cancer using chi-squared tests or t-test to investigate the association between lung cancer and
these parameters. Furthermore, an estimation model for lung cancer risk was built using logis-
tic regression. Before constructing the model, the best threshold for LAA% and HEQ was
selected on the basis of results of t-tests. The statistical models included sex, age, smoking his-
tory (Brinkman index), LAA%, and HEQ as independent variables. The following three statis-
tical models were evaluated: the base model (sex, age, and smoking history); the LAA% model
(base model + LAA%); and the HEQ model (base model + HEQ). Model performance was
assessed using the Akaike information criterion (AIC), analysis of receiver operating charac-
teristic analysis, and the associated areas under the curves (AUCs). Difference in AUCs
between the models was evaluated using Delong’s test. In addition, 10-fold cross validation
was performed for the models to validate their robustness. Finally, the variable HEQ was
binarized based on the empirically determined threshold, and a second HEQ model was
constructed (HEQb). The OR of the HEQb model was calculated to interpret the association
between HEQ and lung cancer risk. P-values of<0.05 were considered significant. All analyses
were performed using R-3.3.2 (available at http://www.r-project.org/).
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Results
Fig 1 presents the patient selection process. A total of 576 patients (317 men and 259 women)
were included, of which 283 were diagnosed with lung cancer and 293 with benign lung nod-
ule. Mean (± standard deviation) patient age of 66.8 ± 12.4 years; mean Brinkman Index (rep-
resenting the smoking history) was 647 ± 829.
Patient demographics and results of emphysema quantification are summarized in Table 1.
Visual scores of emphysema around lung nodules were as follows: no emphysema, 419; mild
emphysema, 47; severe emphysema, 110. Mean LAA% values at the three thresholds were as
follows: −950 HU, 25.2% ± 10.9%; −910 HU, 41.4% ± 13.3%; and −880 HU, 53.3% ± 13.6%.
Mean HEQ values at the three thresholds were as follows: −950 HU, b0 7770 ± 3100, b1
4930 ± 3250; −910 HU, b0 3760 ± 2470, b1 7300 ± 3010; and −880 HU, b0 2030 ± 1850, b1
7470 ± 2410.
Table 2 summarizes the results of univariate statistical analysis. Age, smoking history
(Brinkman Index), b1 at −910 HU, b0 at −880 HU, and b1 at −880 HU significantly differed
between patients with and without lung cancer. Conversely, sex, malignant tumor history,
lung area, and LAA% at the three thresholds did not show statistically significant differences.
Based on results in Table 2, −880 HU was selected as the best threshold for both LAA% and
HEQ, and LAA% at −880 HU and b1 at −880 HU were used for the model construction.
The results of the three models are summarized in Table 3. AUCs were as follows: the base
model, 0.585; the LAA% model, 0.593; and the HEQ model, 0.622. Although sex was not a sig-
nificant parameter in the base and LAA% models, AIC was lower when sex was included in
the two models. LAA% coefficient at −880 HU was not significant in the LAA% model
(P = 0.199). Conversely, the coefficient of b1 at −880 HU was statistically significant in the
HEQ model (P = 0.00487). Delong’s test revealed significant difference in AUC between the
LAA% and HEQ models (P = 0.0455). The receiver operating characteristic curves for the
three models are shown in Fig 2.
Fig 1. Flowchart of the patient selection process.
https://doi.org/10.1371/journal.pone.0210720.g001
Estimation of lung cancer risk using homology
PLOS ONE | https://doi.org/10.1371/journal.pone.0210720 January 22, 2019 4 / 11
AUCs of the models with 10-fold cross validation were as follows: base model, 0.565; LAA%
model, 0.570; and HEQ model, 0.602. Delong’s test for the 10-fold cross validation revealed that
the difference between the LAA% and HEQ models was significant (P = 0.0245). The receiver
operating characteristic curves for the models with 10-fold cross validation are shown in Fig 3.
Table 1. Summary of patient demographics and emphysema quantification.
Variables All Lung cancer Benign lung nodule
Mean SD Mean SD Mean SD
N 576 283 293
Age (years) 66.8 12.4 68.8 9.82 64.9 14.1
Sex (number of men) 317 156 161
Smoking history (Brinkman Index) 647 829 727 866 571 785
Malignant tumor history 146 67 79
Nodule size (mm) 21.2 10.1 23.9 10.5 18.6 8.90
Visual score of emphysema
No emphysema 419 199 220
Mild emphysema 47 31 16
Severe emphysema 110 53 57
Lung area of three slices (mm2) 61800 11900 62300 11100 61300 12500
LAA% at −950 HU 25.2 10.9 25.7 10.2 24.8 11.6
LAA% at −910 HU 41.4 13.3 42.3 12.4 40.6 14.0
LAA% at −880 HU 53.3 13.6 54.4 12.7 52.3 14.3
b0 at −950 HU 7770 3100 7820 3110 7720 3100
b1 at −950 HU 4930 3250 5140 3170 4720 3320
b0 at −910 HU 3760 2470 3590 2450 3910 2480
b1 at −910 HU 7300 3010 7650 2870 6960 3100
b0 at −880 HU 2030 1850 1880 1790 2190 1900
b1 at −880 HU 7470 2410 7760 2250 7200 2520
Abbreviations: LAA%, percentage of low-attenuation lung area; b0, zero-dimensional Betti number; b1, one-dimensional Betti number; SD, standard deviation
https://doi.org/10.1371/journal.pone.0210720.t001




Smoking history (Brinkman Index) 0.0243
Malignant tumor history 0.417�
Lung area of the three slices 0.276
LAA% at −950 HU 0.312
LAA% at −910 HU 0.128
LAA% at −880 HU 0.0648
b0 at −950 HU 0.682
b1 at −950 HU 0.124
b0 at −910 HU 0.122
b1 at −910 HU 0.00536
b0 at −880 HU 0.0421
b1 at −880 HU 0.00517
�Chi-squared test. Remaining variables were tested using t-tests. Abbreviations: LAA%, percentage of low-
attenuation lung area; b0, zero-dimensional Betti number; b1, one-dimensional Betti number.
https://doi.org/10.1371/journal.pone.0210720.t002
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Table 3. Results of the three statistical models for estimating lung cancer risk.
Model Independent variable Coefficient Standard error P AIC
Base model Sex = Male −0.347 0.208 0.0959 785.9
Age 0.0258 0.00731 0.000414
Smoking history (Brinkman Index) 0.000281 0.000128 0.0283
LAA% model Sex = Male −0.379 0.210 0.0710 786.2
Age 0.0248 0.00737 0.000758
Smoking history (Brinkman Index) 0.000273 0.000128 0.0332
LAA% at −880 HU 0.00835 0.00649 0.199
HEQ model Sex = Male −0.438 0.212 0.0393 779.8
Age 0.0260 0.00743 0.000479
Smoking history (Brinkman Index) 0.000294 0.000130 0.0238
b1 at −880 HU 0.000104 0.0000370 0.00487
Abbreviations: AIC, Akaike information criterion; LAA%, percentage of low-attenuation lung area; HEQ, homology-based emphysema quantification; b1, one-
dimensional Betti number
https://doi.org/10.1371/journal.pone.0210720.t003
Fig 2. Results of receiver operating characteristic analysis for the three models for estimating lung cancer risk.
The areas under the curve of the models were as follows: base model, 0.585; LAA% model, 0.593; HEQ model, 0.622.
Abbreviations: LAA%, percentage of low-attenuation lung area; HEQ, homology-based emphysema quantification.
https://doi.org/10.1371/journal.pone.0210720.g002
Estimation of lung cancer risk using homology
PLOS ONE | https://doi.org/10.1371/journal.pone.0210720 January 22, 2019 6 / 11
Table 4 shows the results of the HEQb model, which used binarized values for b1 at −880
HU. Before constructing this model, the value of b1 at −880 HU was replaced by 1 when it was
larger than 5100 or by 0 otherwise. The AUC for the HEQb model was 0.622 without 10-fold
cross validation and 0.602 with 10-fold cross validation. OR (95% confidence interval) for b1
as a binary variable at −880 HU was 2.28 (1.43–3.73).
Fig 3. Results of receiver operating characteristic analysis for the three models with 10-fold cross validation. The
areas under the curve of the models with 10-fold cross validation were as follows: base model, 0.565; LAA% model,
0.570; HEQ model, 0.602. Abbreviations: LAA%, percentage of low-attenuation lung area; HEQ, homology-based
emphysema quantification.
https://doi.org/10.1371/journal.pone.0210720.g003
Table 4. Results for the HEQb model using binarized values of b1 at −880 HU.
Model Independent variable Coefficient P OR 95% confidence interval of OR
HEQb model Sex = Male −0.387 0.0657 0.678 0.448–1.0231
Age 0.0242 0.00114 1.0245 1.00988–1.0399
Smoking history (Brinkman Index) 0.000298 0.0217 1.000298 1.0000478–1.000559
b1 at −880 HU (binarized variable) 0.825 0.000725 2.283 1.426–3.725
The Akaike information criterion value and area under the curve for the HEQb model were 775.9 and 0.622, respectively. Abbreviations: HEQ, homology-based
emphysema quantification; b1, one-dimensional Betti number; OR, odds ratio
https://doi.org/10.1371/journal.pone.0210720.t004
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Discussion
In this study, we evaluated the association between HEQ or LAA% and lung cancer in patients
with lung nodules. After adjusting for age, sex, and smoking history (Brinkman index), HEQ
was significantly associated with lung cancer, while LAA% was not. Moreover, our findings
indicated that the HEQ model was more effective at estimating lung cancer risk than were the
base and LAA% models. In the HEQb model, OR (95% confidence interval) for the binarized
b1 at −880 HU was 2.28 (1.43–3.73), indicating that on average, the odds of developing lung
cancer in patients with high b1 (>5100) at −880 HU were higher by a factor of e2.28� 9.78
than the odds of developing lung cancer in patients with low b1 (�5100).
A previous meta-analysis [7] has shown that although visually assessed emphysema using
CT was independently associated with lung cancer risk, automated emphysema detection
(including LAA%) was not; the pooled ORs (95% confidence intervals) were as follows: visual
assessment of emphysema, 3.50 (2.71–4.51) and automated emphysema detection, 1.16 (0.48–
2.81). Gietema et al have shown that for moderate-to-severe emphysema visualized on CT, the
visual assessment tended to overestimate the extent of emphysema compared with LAA% at
−950 HU [19]. Conversely, for smaller amounts of emphysema, the radiologists tended to
underestimate the extent of emphysema compared with LAA% at −950 HU. Wilson et al have
suggested that automated densitometry for emphysema evaluation was rather sensitive to dis-
tinguish clinically meaningful emphysema with respect to lung cancer risk [20]. On the basis
of these results, we hypothesized that emphysema quantification should strongly correlate
with visual assessment when emphysema quantification is used for the estimation of lung can-
cer risk.
A previous study has investigated the association of emphysema assessed by LAA% and
HEQ with the visual assessment of emphysema [13] and has shown that LAA% at −875 HU
and HEQ at −875 HU were strongly associated with the visual assessment values. Therefore,
we used the threshold of −880 HU for emphysema quantification in the present study in addi-
tion to −950 and −910 HU. This threshold (−880 HU) is not the one typically used for LAA%
in the literature, and it is difficult to compare our results of LAA% with the results of other
studies.
Another previous study has shown that HEQ was useful for evaluating the spatial distribu-
tion of low-attenuation lung regions in patients with and without chronic obstructive pulmo-
nary disease [12]. Gietema et al have shown that the visual assessment of emphysema was
affected by both LAA% and the spatial distribution of low-attenuation lung regions [19]; there-
fore, we speculated that HEQ could be more useful for the estimation of lung cancer risk than
LAA%. Our results validated this speculation, showing that b1 at −880 HU was significantly
associated with lung cancer risk in the HEQ and HEQb models.
Similar to the previous meta-analysis [7], our results showed no statistically significant dif-
ference in the association between lung cancer risk and LAA% at the three thresholds. How-
ever, the association between LAA% and lung cancer risk improved when a relatively high
threshold (−880 HU) was set. We speculated that LAA% using a higher threshold might be sig-
nificantly associated with lung cancer risk. However, we did not pursue this speculation in the
present study, which was designed to evaluate the association between HEQ and lung cancer
risk.
This study had several limitations. First, our results were obtained retrospectively using a
CT database of patients with lung nodules, who visited a single hospital [14],[15]. The patient
demographics and prevalence of lung cancer in the database were different from those of
patients undergoing CT screening. Frequencies of lung nodules and lung cancers in the pres-
ent study were evidently different from those in CT screening; in our study, the frequencies of
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clinically meaningful lung nodules and lung cancers were quite high, and lung cancer preva-
lence was 49.1%. Therefore, our results must be evaluated in another screening population.
Second, the database did not include low-dose CT. Although automated exposure control was
used for scanning in our database, the radiation exposure was higher than that in CT screen-
ing. Previous studies have investigated effects of low-dose CT and iterative reconstruction
on emphysema quantification, particularly on the size distribution of low-attenuation lung
regions. Therefore, with iterative reconstruction, acceptable agreement in emphysema quanti-
fication between low-dose CT and standard-dose CT could be obtained [21]. Hence, we expect
that the results of the present study can be replicated when low-dose CT images are recon-
structed with iterative reconstruction. Third, adjustments for cofounders were limited in the
present study. Only patient age, sex, and smoking history (Brinkman Index) were adjusted in
the models. Previous studies have shown that the results of pulmonary function tests and clini-
cal diagnosis of chronic obstructive pulmonary disease were significantly associated with lung
cancer risk [6],[22]. In addition, several risk prediction models were investigated in previous
studies [4],[5]. In a future study, we aim to explore the added value of HEQ for estimating
lung cancer risk when used in combination with these cofounders and models. Finally, nodule
features (such as shape and size) were not evaluated since we focused on the usefulness of
emphysema quantification for estimating lung cancer risk. Combined use of HEQ and nodule
features may lead to a better model for estimating lung cancer risk although such a model can
only be used when lung nodules are detected.
Conclusions
After adjusting for age, sex, and smoking history (Brinkman index), HEQ was significantly
associated with lung cancer risk, and HEQ can potentially allow the stratification of lung can-
cer risk.
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